https://www.macrotrends.net/stocks/charts/ATHE/alterity-therapeutics--/financial-ratios
Ten years of annual and quarterly financial ratios and margins for analysis of Alterity Therapeutics - (ATHE).
financial ratiosalteritytherapeuticsanalysisathe
https://www.biospace.com/alterity-therapeutics-appoints-phillip-hains-as-chief-financial-officer
Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced the appointment...
chief financial officeralteritytherapeuticsappointsphillip
https://www.writersdigest.com/online-exclusives/science-fiction-first-place-winner-alterity
Read "Alterity" by Emily M. Dietrich, the first place winner in the Science Fiction/ Fantasy category of the 14th Annual Writer's Digest Popular Fiction Awards.
science fictionfirst placewinneralteritywriter
https://www.clinicaltrialsarena.com/news/alterity-multiple-system-atrophy-2/
Alterity Therapeutics has dosed the first participant in Italy in the Phase II clinical trial of ATH434 in multiple system atrophy (MSA).
multiple system atrophyalteritybeginssubjectdosing
https://investorplace.com/2023/12/why-is-alterity-therapeutics-athe-stock-up-150-today/?utm_source=financialcontent&utm_medium=quotes
Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.
alteritytherapeuticsathestocktoday
https://www.macrotrends.net/stocks/charts/ATHE/alterity-therapeutics--/operating-margin
Current and historical operating margin for Alterity Therapeutics - (ATHE) over the last 10 years. The current operating profit margin for Alterity...
operating marginalteritytherapeuticsathemacrotrends
https://alteritysolutions.com/
Traveling Coaches empowers law firms to thrive through award-winning learning programs and strategies tailored to the legal community.
alterity
https://www.globenewswire.com/news-release/2025/09/15/3149876/0/en/Alterity-Therapeutics-Presents-ATH434-201-Phase-2-Data-at-the-American-Neurological-Association-Annual-Meeting.html
ATH434 demonstrated clinically meaningful efficacy in modifying disease progression and was well tolerated at both 50 and 75 mg doses...
alteritytherapeuticspresentsphasedata
https://www.benzinga.com/news/23/01/30389571/5-most-expensive-health-care-stocks-you-should-worry-about
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
health careexpensivestocksworry